Evidence map›Paper›PMID 41786949›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026

Patient-reported outcomes and speech-in-noise performance with OSIA versus other transcranial devices in unilateral and asymmetric hearing loss.

Stéphane Rossetto, Haddad Ralph, Laetitia Ros, Rim Bechraoui, Jean-Baptiste Morvan, Arnaud Deveze, Vatin Loraine, Zidi Amine, Gargula Stéphane

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stéphane RossettoAix Marseille Univ, APHM, La Conception University Hospital, ENT-HNS Department, Marseille, France.
Haddad RalphAix Marseille Univ, APHM, La Conception University Hospital, ENT-HNS Department, Marseille, France.
Laetitia RosAix Marseille Univ, APHM, La Conception University Hospital, ENT-HNS Department, Marseille, France.
Rim BechraouiAix Marseille Univ, APHM, La Conception University Hospital, ENT-HNS Department, Marseille, France.
Jean-Baptiste MorvanSte Anne Army Training Hospital, Department of ENT, 2 boulevard Ste Anne, BP 600, Toulon, 83800, France.
Arnaud DevezeAix Marseille Univ, APHM, La Conception University Hospital, ENT-HNS Department, Marseille, France.
Vatin LoraineSte Anne Army Training Hospital, Department of ENT, 2 boulevard Ste Anne, BP 600, Toulon, 83800, France.
Zidi AmineORL, Otoneurology and ORL pediatric department, CHU Toulouse, Toulouse, France.
Gargula StéphaneAix Marseille Univ, APHM, La Conception University Hospital, ENT-HNS Department, Marseille, France. stephane.gargula@gmail.com.ORCID http://orcid.org/0000-0002-5034-4210

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSingle-sided deafness (SSD) and asymmetric hearing loss (AHL) impair binaural hearing, reducing speech-in-noise perception, sound localization, and quality of life. Treatment options include bone conduction devices (BAHA, Bonebridge, OSIA) and CROS/BICROS hearing aids. The OSIA system is the most recent option, but comparative real-life data, particularly on patient-reported outcomes, remain scarce. This is the first study to assess the OSIA system in SSD and AHL patients using the Bern Benefit in Single-Sided Deafness (BBSS) questionnaire.

methodsWe retrospectively analyzed SSD and AHL patients who completed a trial with a transcranial device or CROS/BICROS, followed by implantation or fitting. Speech-in-noise performance (signal-to-noise ratio, SNR) and BBSS scores were collected at the end of the trial and at 4 months. Outcomes were compared across device groups, and correlations between objective and subjective measures were explored.

resultsAt 4 months, OSIA users reported higher BBSS scores, but similar differences were already observed at the end of the trial, despite identical headband testing. This suggests an influence of patient expectations or profiles rather than device-specific effects. Music perception improved between trial and follow-up in OSIA and BAHA users. SNR gains correlated with several BBSS items at the end of the trial but not at 4 months. Overall, BBSS scores remained stable over time.

conclusionAll transcranial devices yielded early and sustained subjective benefit in SSD and AHL. OSIA users reported higher perceived benefit, though baseline differences may explain this. BBSS stability suggests benefit is established early and not strongly influenced by device technology.

Indexed as

Hearing AidsHearing Loss, UnilateralPatient Reported Outcome MeasuresSpeech PerceptionAdultAgedAuditory AcuityFemaleHumansMaleMiddle AgedNoiseQuality of LifeRetrospective StudiesSound LocalizationSurveys and QuestionnairesBone conductionHearing aidsHearing loss, unilateralPatient reported outcome measuresQuality of lifeSpeech perception

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.